Aridis Pharmaceuticals, Inc.
ARDSDelisted Sep 8, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001614067
Aridis Pharmaceuticals, Inc. was delisted on Sep 8, 2023; its insiders filed their last Form 4 on Jun 28, 2024; 18 institutions reported holding it in 13F filings for Q2 2023, worth $392.3K in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Aridis Pharmaceuticals, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- +1 vs. Q3 2022
- Shares held
- 3.88M
- +1.96M (+101.6%) vs. Q3 2022
- Total value
- $4.58M
- +$2.79M (+155.8%) vs. Q3 2022
- New holders
- 3
- 5 more added
- Sold out
- 2
- 4 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARDS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $1 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $3 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 2 | $10 |
| Q3 2023 | 1 | $1.44K |
| Q2 2023 | 18 | $392.3K |
| Q1 2023 | 20 | $1.29M |
| Q4 2022 | 17 | $4.58M |
| Q3 2022 | 16 | $1.79M |
| Q2 2022 | 19 | $2.05M |
| Q1 2022 | 22 | $3.38M |
| Q4 2021 | 20 | $2.96M |
| Q3 2021 | 18 | $7.33M |
| Q2 2021 | 13 | $7.87M |
| Q1 2021 | 12 | $5.97M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Aridis Pharmaceuticals, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 2,068,000 | $2.44M | 0.07% | +2,068,000 | New |
| Commonwealth Equity Services, LLC | 575,000 | $678.0K | 0.00% | +7,800+1.4% | Added |
| Vanguard Group Inc | 524,453 | $618.9K | 0.00% | +331+0.1% | Added |
| Roumell Asset Management, LLC | 446,588 | $527.0K | 1.30% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 143,034 | $168.0K | 0.00% | +7,013+5.2% | Added |
| State Street Corp | 43,247 | $51.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 28,104 | $33.2K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 17,263 | $20.4K | 0.00% | −185−1.1% | Reduced |
| Wealth Architects, LLC | 14,077 | $16.6K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 9,630 | $11.0K | 0.00% | −1,039−9.7% | Reduced |
| UBS Group AG | 7,668 | $9.05K | 0.00% | +4,471+139.8% | Added |
| Group One Trading, L.P. | 3,202 | $3.78K | 0.00% | −15,297−82.7% | Reduced |
| Simplex Trading, LLC | 1,719 | $2.00K | 0.00% | −10,153−85.5% | Reduced |
| Wells Fargo & Company | 1,378 | $1.63K | 0.00% | +47+3.5% | Added |
| Financial Perspectives, Inc | 250 | $295 | 0.00% | 00.0% | Unchanged |
| ICA Group Wealth Management, LLC | 250 | $295 | 0.00% | +250 | New |
| Bank of America Corp | 40 | $48 | 0.00% | +40 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −54,386−100.0% | Sold out |
| EP Wealth Advisors, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |